190 related articles for article (PubMed ID: 35803923)
1. The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism.
Michaud V; Lasseaux E; Green DJ; Gerrard DT; Plaisant C; ; Fitzgerald T; Birney E; Arveiler B; Black GC; Sergouniotis PI
Nat Commun; 2022 Jul; 13(1):3939. PubMed ID: 35803923
[TBL] [Abstract][Full Text] [Related]
2. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human induced pluripotent stem cell line carrying the TYR c.575C>A (p.Ser192Tyr) and c.1205G>A (p.Arg402Gln) variants in homozygous state using CRISPR-Cas9 genome editing.
Liu J; Black GC; Kimber SJ; Sergouniotis PI
Stem Cell Res; 2022 Oct; 64():102880. PubMed ID: 35933957
[TBL] [Abstract][Full Text] [Related]
4. Genetic Linkage between
Bjeloš M; Ćurić A; Bušić M; Rak B; Kuzmanović Elabjer B
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928147
[TBL] [Abstract][Full Text] [Related]
5. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
[TBL] [Abstract][Full Text] [Related]
6. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
8. A multilayered approach to the analysis of genetic data from individuals with suspected albinism.
Sergouniotis PI; Michaud V; Lasseaux E; Campbell C; Plaisant C; Javerzat S; Birney E; Ramsden SC; Black GC; Arveiler B
J Med Genet; 2023 Nov; 60(12):1245-1249. PubMed ID: 37460203
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
Liu J; Choy KW; Chan LW; Leung TY; Tam PO; Chiang SW; Lam DS; Pang CP; Lai TY
Clin Exp Ophthalmol; 2010 Jan; 38(1):37-42. PubMed ID: 20447099
[TBL] [Abstract][Full Text] [Related]
10. Oculocutaneous albinism type 1B associated with a functionally significant tyrosinase gene polymorphism detected with Whole Exome Sequencing.
Mendez R; Iqbal S; Vishnopolska S; Martinez C; Dibner G; Aliano R; Zaiat J; Biagioli G; Fernandez C; Turjanski A; Campbell AJ; Mercado G; Marti MA
Ophthalmic Genet; 2021 Jun; 42(3):291-295. PubMed ID: 33599182
[No Abstract] [Full Text] [Related]
11. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
12. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China.
Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S
Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
[TBL] [Abstract][Full Text] [Related]
14. [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals].
Sanabria D; Groot H; Guzmán J; Lattig MC
Biomedica; 2012 Jun; 32(2):269-76. PubMed ID: 23242301
[TBL] [Abstract][Full Text] [Related]
15. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
Mondal M; Sengupta M; Ray K
Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
Kessel L; Kjer B; Lei U; Duno M; Grønskov K
Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
[TBL] [Abstract][Full Text] [Related]
18. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinase (TYR) gene sequencing and literature review reveals recurrent mutations and multiple population founder gene mutations as causative of oculocutaneous albinism (OCA) in Pakistani families.
Shakil M; Harlalka GV; Ali S; Lin S; D'Atri I; Hussain S; Nasir A; Shahzad MA; Ullah MI; Self JE; Baple EL; Crosby AH; Mahmood S
Eye (Lond); 2019 Aug; 33(8):1339-1346. PubMed ID: 30996339
[TBL] [Abstract][Full Text] [Related]
20. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
